Imprida Tablet 5/160 mg
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
MFDS item code 201305048 · Approved 2013.02.15
This product's status changed to Approval withdrawn on 2023.06.26. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement in blood pressure control in essential hypertension with combination of amlodipine and valsartan
This medicine is used for patients with essential hypertension who do not have adequate blood pressure control with monotherapy of amlodipine or valsartan.
The recommended dose for this medication is 1 tablet once daily, taken with water regardless of meals. It is recommended to take it at the same time each day (e.g., in the morning) if possible.
Safety and efficacy have not been established for pediatric patients under 18 years of age, so its use is not recommended.
This medication can cause serious harm or death to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it must be discontinued immediately upon confirmation of pregnancy. Patients with allergies to this medication's active ingredients or similar class medications, women who are pregnant or breastfeeding, and patients with severe kidney or liver dysfunction should not take this drug. Patients who are depleted of sodium or fluids may experience hypotension, so their condition should be evaluated carefully before taking the medication, and blood pressure and condition monitored closely during treatment. Patients with high potassium levels or those taking potassium supplements need regular monitoring of potassium levels, and caution is needed for patients with vascular issues in the kidneys. Caution is also advised for patients with cardiac conditions, such as heart failure or after myocardial infarction, and patients with aortic stenosis. If symptoms of angioedema occur, the medication should be stopped immediately and not resumed. Caution is required when driving or operating machinery due to potential dizziness or fatigue. This medication may increase the risk of hypotension, hyperkalemia, or renal impairment when used in combination with other antihypertensives, so blood pressure and renal function should be closely monitored when used together. Women who are pregnant or planning pregnancy should not take this medication, and its use is not recommended in nursing mothers. Safety and efficacy have not been sufficiently established in pediatric patients, so its use is discouraged. In the event of overdose, hypotension or serious side effects may occur, so dosage must be strictly adhered to, and medical attention sought immediately if unusual symptoms appear.
Hives, severe swelling (edema), angioedema, chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain in mucous membranes of lips/eyes, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities along with cough and fever, yellowing of skin or eyes (jaundice), extreme fatigue, sudden and severe headache, thunderclap headache, seizures, altered consciousness, visual disturbances,
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture, and it is safe to store it at room temperature between 1 degree and 30 degrees Celsius. This storage condition helps maintain the efficacy of the medication and prevent deterioration.
Dark yellow oval film-coated tablet
28 tablets (14 tablets/PTP packaging X2), 28 tablets (7 tablets/PTP packaging X4)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.